RxDoctor Payments Data

Maksim Blidchenko

Nurse Practitioner · Des Moines, IANPI 1013559178

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,911 of the $3,996 with a category attached, or 72.8%. 10 manufacturers reported payments, led by Boston Scientific at 42.1% of the total. Reporting peaked in 2023 at $1,981 and has fallen 69.2% since, to $610 in 2025. Among nurse practitioner clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,996in general payments, 2019–2025

Across 65 payments — averaging $61.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Medtronic$777
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$529
  • E.r. Squibb & Sons, L.L.C.$392
  • Atricure, Inc.$379
  • Pfizer$105
  • plus $130 from 4 others

What the payments were for

  • Travel & lodging$1,08627%
  • Food & beverage$2,91173%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,996 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in Iowa.

See all nurse practitioner providers in Iowa

Medicare billing

Part B allowed, 2024
$25,282
Medicare patients
284
Services billed
672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban345$262,441
XareltoRivaroxaban80$59,531
Dofetilide17$6,467
Metoprolol Succinate483$4,564
Amiodarone Hcl288$3,832
SotalolSotalol Hcl94$1,851
Flecainide Acetate69$1,803
Diltiazem 24hr Er (Cd)Diltiazem Hcl62$1,072
Bisoprolol Fumarate17$664
Dilt-XrDiltiazem Hcl49$635
Potassium Chloride33$326
Digoxin18$271
Diltiazem 24hr Er (Xr)Diltiazem Hcl14$259
Diltiazem 24hr ErDiltiazem Hcl14$214
Metoprolol Tartrate70$203

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$105$262,441345 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in Iowa.

Other nurse practitioner in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →